We use cookies for a better user experience. Read our Privacy Policy

I Agree

Monocyte Activation Tests Market

Monocyte Activation Tests Market (Product - Monocyte Activation Test Kits and Reagents; Source- Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based; Application - Lipid Parenteral, Dialysis Liquids, Toxic/immune-modulatory Drugs, Blood Products and Medical Devices; Industry - Pharmaceuticals, Biotechnology, Medical Devices ) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Some of the most important factors likely to drive the development of the global monocyte activation tests market include a rise in the number of pharmaceutical and biotechnology firms globally, a rapidly increasing approvals of new drugs. Besides rising investments dedicated to advancing research and development of new testing technologies is estimated to boost sales opportunities in the global market. In addition to that , growing medical and healthcare spending, regular launch of new biological product lines, an increase in the number of innovative and novel drugs, and an increase in regulatory and public concerns about product safety are all likely to drive the global monocyte activation tests market forward in the coming years.

In order to increase their present product portfolios, manufacturers and players in the global monocyte activation tests market are constantly developing new test solutions. The presence of key international as well as local players in the global monocyte activation tests market is also likely to assist the industry's expansion. In addition, one of the most important factors impacting the revenue generation of the global monocyte activation tests market is the recommended restriction on animal testing in order to limit the use of rabbit pyrogens testing. Additionally, the expanding presence of numerous contract research organizations, or CROs, is likely to boost the global monocyte activation tests market's commercial progress in the approaching years.

According to the World Health Organization (WHO), about 12.5 million blood donations are gathered globally, with almost half of them being collected in developed countries, which account for 19% of the global population. The manufacture of MAT kits and reagents is hampered by a scarcity of healthy blood donors, which has an impact on market growth. In addition, the pyrogen test was introduced in various applications. Pharmaceutical items, such as medications and immunological products, are subjected to the pyrogen test. It is now employed in medical devices, implants, water filtration, and the food and beverage sectors.

monocyte-activation-test-market.jpg

Increasing Demand for Use in Pyrogen Testing to Bolster Growth of the Market

Insufficient availability of monocyte activation reagents and tests, on the other hand, may limit the global monocyte activation tests market's development in the forthcoming years. Cell line based tests, b lood based tests, and peripheral blood mononuclear cell or PBMC based testing are the three types of tests supplied by companies in the global monocyte activation tests market. Lipid parenteral, hazardous or immune modulatory medicines, and dialysis solutions are some of the applications for the items in the global market. Medical device, pharmaceutical, and biotechnology industries are among the most prominent end consumers for the goods and solutions supplied by companies and manufacturers in the global monocyte activation tests market.

Pyrogens are chemicals that cause fever when injected into the bloodstream. The introduction of dangerous pyrogens into the body causes bodily discomfort and an increase in body temperature. The presence of pyrogen and endotoxin compounds is determined by monocyte activation tests. The need for pyrogen testing is presently not restricted to pharmaceutical and biological firms, but is growing amongst a variety of different end users.

The global monocyte activation tests market is seeing constant innovation in test products, as well as a diverse product range from big and local producers. The expanding number of biotechnology and pharmaceutical businesses internationally, increased research and development spending, and rising new medication approvals are all driving the global monocyte activation tests market forward. Furthermore, factors such as rising healthcare spending, the introduction of new novel pharmaceuticals and biological products, and rising public and regulatory concerns about product safety all contribute to market growth.

Asia Pacific to Emerge as One of the Rapidly Growing Regions in the Market

The North America monocyte activation testing market is expected to grow at a moderate growth rate. The  reagent product type segment is expected to dominate the North America market. In terms of growth rate, Asia Pacific is predicted to be one of the rapidly growing regions throughout the forecast period. Increased research efforts in drug discovery and expanding awareness regarding animal-free endotoxin detection are two main factors fueling the growth of the monocyte activation testing market in Europe. The global monocyte activation tests market is largely driven by the rapidly developing medical devices, pharmaceutical, and biotechnology industries. Furthermore, rising government funding and, as a result, the launch of new pharmaceuticals is propelling the global monocyte activation tests market forward.

The global monocyte activation tests market is segmented as given below:

Product

  • Monocyte Activation Test Kits
  • Reagents

Source

  • Blood Based
  • Peripheral Blood Mononuclear Bell (PBMC) Based
  • Cell line Based

Application

  • Lipid Parenteral
  • Dialysis Liquids
  • Toxic/immune-modulatory Drugs
  • Blood Products
  • Medical Devices

End-user

  • Pharmaceuticals Industry
  • Biotechnology Industry
  • Medical Devices Industry
  • Others

Revenue

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific (Except Japan)
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa
Monocyte Activation Tests Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of monocyte activation tests market?

The global monocyte activation tests market was worth US$ 5.0 Mn and is projected to reach a value of US$ 19.0 mn by the end of 2025

What is the anticipated CAGR of the monocyte activation tests market in the forecast period?

Monocyte activation tests market is anticipated to grow at a CAGR of 14% during the forecast period

Which region is expected to project the highest market share in the global monocyte activation tests market?

North America accounted for a major share of the global monocyte activation tests market

What are the key driving factors for the growth of the monocyte activation tests market?

Monocyte activation tests market is driven by rise in the number of pharmaceutical and biotechnology firms globally, a rapidly increasing approvals of new drugs

What will be the forecast period in the monocyte activation tests market?

The Forecast period considered for the monocyte activation tests market report is 2017 – 2025

1. Preface 
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Monocyte Activation Test Market

4. Market Overview
     4.1. Introduction
            4.1.1. Product Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview 
     4.3. Market Dynamics
            4.3.1. Drivers 
            4.3.2. Restraints
            4.3.3. Opportunities
     4.4. Global Monocyte Activation Test Market Analysis and Forecasts, 2015–2025
     4.5. Porter's Five Forces Analysis
     4.6. Advancement in Pyrogen Tests
     4.7. Healthcare Industry Overview
     4.8. Global Monocyte Activation Test (MAT): Turnaround Time

5. Global Monocyte Activation Test Market Analysis and Forecasts, By Product
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Market Value Forecast By Product, 2015–2025 
            5.3.1. Monocyte Activation Test Kits
            5.3.2. Reagents
     5.4. Market Attractiveness By Product

6. Global Monocyte Activation Test Market Analysis and Forecasts, By Source
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Market Value Forecast By Source, 2015–2025
            6.3.1. Blood Based
            6.3.2. Peripheral Blood Mononuclear Cell (PBMC) Based
            6.3.3. Cell Line Based
     6.4. Market Attractiveness By Source

7. Global Monocyte Activation Test Market Analysis and Forecasts, By Application
     7.1. Introduction and Definition
     7.2. Key Findings / Developments
     7.3. Market Value Forecast By Application, 2015–2025
            7.3.1. Lipid Parenteral
            7.3.2. Dialysis Liquids
            7.3.3. Toxic/immune-modulatory Drugs
            7.3.4. Blood Products
            7.3.5. Medical Devices
     7.4. Market Attractiveness By Application

8. Global Monocyte Activation Test Market Analysis and Forecasts, By End-user
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Market Value Forecast By End-user, 2015–2025
            8.3.1. Pharmaceuticals Industry
            8.3.2. Biotechnology Industry
            8.3.3. Medical devices Industry
            8.3.4. Others
     8.4. Market Attractiveness By End-user

9. Global Monocyte Activation Test Market Analysis and Forecasts, By Region 
     9.1. Key Findings
     9.2. Market Value Share Analysis and Forecast (2015-2025), By Region
            9.2.1. North America
            9.2.2. Europe
            9.2.3. Asia Pacific
            9.2.4. Latin America
            9.2.5. Middle East & Africa
     9.3. Market Attractiveness by Region

10. North America Monocyte Activation Test Market Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
     10.2. Market Forecast By Product, 2015–2025
            10.2.1. Monocyte Activation Test Kits
            10.2.2. Reagents
     10.3. Market Forecast By Source, 2015–2025
            10.3.1. Blood Based
            10.3.2. Peripheral Blood Mononuclear Cell (PBMC) Based
            10.3.3. Cell Line Based
     10.4. Market Forecast By Application, 2015–2025
            10.4.1. Lipid Parenteral
            10.4.2. Dialysis Liquids
            10.4.3. Toxic/immune-modulatory Drugs
            10.4.4. Blood Products
            10.4.5. Medical Devices
     10.5. Market Forecast By End-users, 2015–2025
            10.5.1. Pharmaceuticals industry
            10.5.2. Biotechnology industry
            10.5.3. Medical devices industry
            10.5.4. Others
     10.6. Market Forecast By Country, 2015–2025
            10.6.1. U.S.
            10.6.2. Canada
     10.7. Market Attractiveness Analysis 
            10.7.1. By Product
            10.7.2. By Source
            10.7.3. By Application
            10.7.4. By End-user
            10.7.5. By Country

11. Europe Monocyte Activation Test Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
     11.2. Market Forecast By Product, 2015–2025
            11.2.1. Monocyte Activation Test Kits
            11.2.2. Reagents
     11.3. Market Forecast By Source, 2015–2025
            11.3.1. Blood Based
            11.3.2. Peripheral Blood Mononuclear Cell (PBMC) Based
            11.3.3. Cell Line Based
     11.4. Market Forecast By Application, 2015–2025
            11.4.1. Lipid parenteral
            11.4.2. Dialysis liquids
            11.4.3. Toxic/immune-modulatory drugs
            11.4.4. Blood products
            11.4.5. Medical devices
     11.5. Market Forecast By End-users, 2015–2025
            11.5.1. Pharmaceuticals industry
            11.5.2. Biotechnology industry
            11.5.3. Medical devices industry
            11.5.4. Others
     11.6. Market Forecast By Country, 2015–2025
            11.6.1. Germany
            11.6.2. France
            11.6.3. U.K.
            11.6.4. Spain
            11.6.5. Italy
            11.6.6. Rest of Europe
     11.7. Market Attractiveness Analysis 
            11.7.1. By Product
            11.7.2. By Source
            11.7.3. By Application
            11.7.4. By End-user
            11.7.5. By Country

12. Asia Pacific Monocyte Activation Test Market Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
     12.2. Market Forecast By Product, 2015–2025
            12.2.1. Monocyte Activation Test Kits
            12.2.2. Reagents
     12.3. Market Forecast By Source, 2015–2025
            12.3.1. Blood Based
            12.3.2. Peripheral Blood Mononuclear Cell (PBMC) Based
            12.3.3. Cell Line Based
     12.4. Market Forecast By Application, 2015–2025
            12.4.1. Lipid parenteral
            12.4.2. Dialysis liquids
            12.4.3. Toxic/immune-modulatory drugs
            12.4.4. Blood products
            12.4.5. Medical devices
     12.5. Market Forecast By End-users, 2015–2025
            12.5.1. Pharmaceuticals industry
            12.5.2. Biotechnology industry
            12.5.3. Medical devices industry
            12.5.4. Others
     12.6. Market Forecast By Country, 2015–2025
            12.6.1. China
            12.6.2. Japan
            12.6.3. India
            12.6.4. Australia & New Zealand
            12.6.5. Rest of Asia Pacific 
     12.7. Market Attractiveness Analysis 
            12.7.1. By Product 
            12.7.2. By Source
            12.7.3. By Application
            12.7.4. By End-user
            12.7.5. By Country

13. Latin America Monocyte Activation Test Market Analysis and Forecast
     13.1. Introduction
            13.1.1. Key Findings
     13.2. Market Forecast By Product, 2015–2025
            13.2.1. Monocyte Activation Test Kits
            13.2.2. Reagents
     13.3. Market Forecast By Source, 2015–2025
            13.3.1. Blood Based
            13.3.2. Peripheral Blood Mononuclear Cell (PBMC) Based
            13.3.3. Cell Line Based
     13.4. Market Forecast By Application, 2015–2025
            13.4.1. Lipid parenteral
            13.4.2. Dialysis liquids
            13.4.3. Toxic/immune-modulatory drugs
            13.4.4. Blood products
            13.4.5. Medical devices
     13.5. Market Forecast By End-users, 2015–2025
            13.5.1. Pharmaceuticals industry
            13.5.2. Biotechnology industry
            13.5.3. Medical devices industry
            13.5.4. Others
     13.6. Market Forecast By Country, 2015–2025
            13.6.1. Brazil
            13.6.2. Mexico
            13.6.3. Rest of Latin America
     13.7. Market Attractiveness Analysis 
            13.7.1. By Product
            13.7.2. By Source
            13.7.3. By Application
            13.7.4. By End-user
            13.7.5. By Country

14. Middle East & Africa Monocyte Activation Test Market Analysis and Forecast
     14.1. Introduction
            14.1.1. Key Findings
     14.2. Market Forecast By Product, 2015–2025
            14.2.1. Monocyte Activation Test Kits
            14.2.2. Reagents
     14.3. Market Forecast By Source, 2015–2025
            14.3.1. Blood Based
            14.3.2. Peripheral Blood Mononuclear Cell (PBMC) Based
            14.3.3. Cell Line Based
     14.4. Market Forecast By Application, 2015–2025
            14.4.1. Lipid parenteral
            14.4.2. Dialysis liquids
            14.4.3. Toxic/immune-modulatory drugs
            14.4.4. Blood products
            14.4.5. Medical devices
     14.5. Market Forecast By End-users, 2015–2025
            14.5.1. Pharmaceuticals industry
            14.5.2. Biotechnology industry
            14.5.3. Medical devices industry
            14.5.4. Others
     14.6. Market Forecast By Country, 2015–2025
            14.6.1. South Africa
            14.6.2. Israel
            14.6.3. GCC
            14.6.4. Rest of Middle East & Africa
     14.7. Market Attractiveness Analysis 
            14.7.1. By Product
            14.7.2. By Source
            14.7.3. By Application
            14.7.4. By End-user
            14.7.5. By Country

15. Competition Landscape
     15.1. Key Players & Their Competitive Positioning (2016)
     15.2. Market Player – Competition Matrix (By Tier and Size of companies)
     15.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy) 
            15.3.1. Merck KGaA
                      15.3.1.1. Overview (HQ, Employee Strength, Business Segments)
                      15.3.1.2. Financials
                      15.3.1.3. Recent Developments
                      15.3.1.4. SWOT Analysis
                      15.3.1.5. Strategy
            15.3.2. Thermo Fisher Scientific
                      15.3.2.1. Overview (HQ, Employee Strength, Business Segments)
                      15.3.2.2. Financials
                      15.3.2.3. Recent Developments
                      15.3.2.4. SWOT Analysis
                      15.3.2.5. Strategy
            15.3.3. Charles River Laboratories International, Inc.
                      15.3.3.1. Overview (HQ, Employee Strength, Business Segments)
                      15.3.3.2. Financials
                      15.3.3.3. Recent Developments
                      15.3.3.4. SWOT Analysis
                      15.3.3.5. Strategy
            15.3.4. Sanquin
                      15.3.4.1. Overview (HQ, Employee Strength, Business Segments)
                      15.3.4.2. Financials
                      15.3.4.3. Recent Developments
                      15.3.4.4. SWOT Analysis
                      15.3.4.5. Strategy
            15.3.5. Microcoat Biotechnologie GmbH
                      15.3.5.1. Overview (HQ, Employee Strength, Business Segments)
                      15.3.5.2. Recent Developments
                      15.3.5.3. SWOT Analysis
                      15.3.5.4. Strategy
            15.3.6. Becton, Dickinson and Company
                      15.3.6.1. Overview (HQ, Employee Strength, Business Segments)
                      15.3.6.2. Financials
                      15.3.6.3. Recent Developments
                      15.3.6.4. SWOT Analysis
                      15.3.6.5. Strategy
            15.3.7. SOLVIAS AG
                      15.3.7.1. Overview (HQ, Employee Strength, Business Segments)
                      15.3.7.2. Financials
                      15.3.7.3. Recent Developments
                      15.3.7.4. SWOT Analysis
                      15.3.7.5. Strategy
            15.3.8. Lonza Group
                      15.3.8.1. Overview (HQ, Employee Strength, Business Segments)
                      15.3.8.2. Financials
                      15.3.8.3. Recent Developments
                      15.3.8.4. SWOT Analysis
                      15.3.8.5. Strategy

List of Tables

Table 01: Global Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Product, 2015–2025
Table 02: Global Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Source, 2015–2025
Table 03: Global Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Application, 2015–2025
Table 04: Global Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by End-user, 2015–2025
Table 05: Global Monocyte Activation Tests Market Size (US$ Thousand) Forecast, by Region, 2015–2025
Table 06: North America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Country, 2015–2025
Table 07: North America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Product, 2015–2025
Table 08: North America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Source, 2015–2025
Table 09: North America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Application, 2015–2025
Table 10: North America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by End-user, 2015–2025
Table 11: Europe Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2015–2025
Table 12: Europe Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Product, 2015–2025
Table 13: Europe Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Source, 2015–2025
Table 14: Europe Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Application, 2015–2025
Table 15: Europe Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by End-user, 2015–2025
Table 16: Asia Pacific Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2015–2025
Table 17: Asia Pacific Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Product, 2015–2025
Table 18: Asia Pacific Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Source, 2015–2025
Table 19: Asia Pacific Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Application, 2015–2025
Table 20: Asia Pacific Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by End-user, 2015–2025
Table 21: Latin America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2015–2025
Table 22: Latin America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Product, 2015–2025
Table 23: Latin America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Source, 2015–2025
Table 24: Latin America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Application, 2015–2025
Table 25: Latin America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by End-user, 2015–2025
Table 26: Middle East & Africa Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2015–2025
Table 27: Middle East & Africa Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Product, 2015–2025
Table 28: Middle East & Africa Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Source, 2015–2025
Table 29: Middle East & Africa Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Application, 2015–2025
Table 30: Middle East & Africa Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by End-user, 2015–2025

List of Figures

Figure 01. Global Monocyte Activation Tests Market Size (US$ Thousand) and Distribution, by Region, 2017 and 2025
Figure 02: Global Monocyte Activation Tests Market Value (US$ Thousand) Forecast, 2015–2025
Figure 03: Global Monocyte Activation Tests Market Value Share, by Product (2016)
Figure 04: Global Monocyte Activation Tests Market Value Share, by Source (2016)
Figure 05: Global Monocyte Activation Tests Market Value Share, by Application (2016)
Figure 06: Global Monocyte Activation Tests Market Value Share, by End-user (2016)
Figure 07: Global Monocyte Activation Tests Market Value Share, by Product, 2017 and 2025
Figure 08: Global Monocyte Activation Tests Market Revenue (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, by Monocyte Activation Tests Kits, 2015–2025
Figure 09: Global Monocyte Activation Tests Market Revenue (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, by Reagents, 2015–2025
Figure 10: Global Monocyte Activation Tests Market Attractiveness, by Product, 2017–2025
Figure 11: Global Monocyte Activation Tests Market Value Share, by Source, 2017 and 2025
Figure 12: Global Monocyte Activation Tests Market Revenue (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, by Blood-based, 2015–2025
Figure 13: Global Monocyte Activation Tests Market Revenue (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, by PBMC-based, 2015–2025
Figure 14: Global Monocyte Activation Tests Market Revenue (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, by Cell Line-based, 2015–2025
Figure 15: Global Monocyte Activation Tests Market Attractiveness, by Source, 2017–2025
Figure 16: Global Monocyte Activation Tests Market Value Share, by Application, 2017 and 2025
Figure 17: Global Monocyte Activation Tests Market Revenue (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, by Lipid Parenteral, 2015–2025
Figure 18: Global Monocyte Activation Tests Market Revenue (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, by Dialysis Liquids, 2015–2025
Figure 19: Global Monocyte Activation Tests Market Revenue (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, by Toxic/immune-modulatory Drugs, 2015–2025
Figure 20: Global Monocyte Activation Tests Market Revenue (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, by Blood Products, 2015–2025
Figure 21: Global Monocyte Activation Tests Market Revenue (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, by Medical Devices, 2015–2025
Figure 22: Global Monocyte Activation Tests Market Attractiveness, by Application, 2017–2025
Figure 23: Global Monocyte Activation Tests Market Value Share, by End-user, 2017 and 2025
Figure 24: Global Monocyte Activation Tests Market Revenue (US$ Thousand) and Y-o-Y Growth (%) Forecast, by Pharmaceuticals Industry, 2015–2025
Figure 25: Global Monocyte Activation Tests Market Revenue (US$ Thousand) and Y-o-Y Growth (%) Forecast, by Biotechnology Industry, 2015–2025
Figure 26: Global Monocyte Activation Tests Market Revenue (US$ Thousand) and Y-o-Y Growth (%) Forecast, by Medical Devices Industry, 2015–2025
Figure 27: Global Monocyte Activation Tests Market Revenue (US$ Thousand) and Y-o-Y Growth (%) Forecast, by Others, 2015–2025
Figure 28: Global Monocyte Activation Tests Market Attractiveness, by End-user, 2017–2025
Figure 29: Global Monocyte Activation Tests Market Value Share, by Region, 2017 and 2025
Figure 30: Global Monocyte Activation Tests Market Attractiveness, by Region, 2017–2025
Figure 31: North America Monocyte Activation Tests Market Value (US$ Thousand) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 32: North America Monocyte Activation Tests Market Value Share, by Country, 2017 and 2025
Figure 33: North America Monocyte Activation Tests Market Attractiveness, by Country, 2017–2025
Figure 34: North America Monocyte Activation Tests Market Attractiveness, by Product, 2017–2025
Figure 35: North America Monocyte Activation Tests Market Attractiveness, by Source, 2017–2025
Figure 36: North America Monocyte Activation Tests Market Attractiveness, by Application, 2017–2025
Figure 37: North America Monocyte Activation Tests Market Attractiveness, by End-user, 2017–2025
Figure 38: Europe Monocyte Activation Tests Market Value (US$ Thousand) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 39: Europe Monocyte Activation Tests Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 40: Europe Monocyte Activation Tests Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 41: Europe Monocyte Activation Tests Market Attractiveness, by Product, 2017–2025
Figure 42: Europe Monocyte Activation Tests Market Attractiveness, by Source, 2017–2025
Figure 43: Europe Monocyte Activation Tests Market Attractiveness, by Application, 2017–2025
Figure 44: Europe Monocyte Activation Tests Market Attractiveness, by End-user, 2017–2025
Figure 45: Asia Pacific Monocyte Activation Tests Market Value (US$ Thousand) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 46: Asia Pacific Monocyte Activation Tests Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 47: Asia Pacific Monocyte Activation Tests Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 48: Asia Pacific Monocyte Activation Tests Market Attractiveness, by Product, 2017–2025
Figure 49: Asia Pacific Monocyte Activation Tests Market Attractiveness, by Source, 2017–2025
Figure 50: Asia Pacific Monocyte Activation Tests Market Attractiveness, by Application, 2017–2025
Figure 51: Asia Pacific Monocyte Activation Tests Market Attractiveness, by End-user, 2017–2025
Figure 52: Latin America Monocyte Activation Tests Market Value (US$ Thousand) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 53: Latin America Monocyte Activation Tests Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 54: Latin America Monocyte Activation Tests Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 55: Latin America Monocyte Activation Tests Market Attractiveness, by Product, 2017–2025
Figure 56: Latin America Monocyte Activation Tests Market Attractiveness, by Source, 2017–2025
Figure 57: Latin America Monocyte Activation Tests Market Attractiveness, by Application, 2017–2025
Figure 58: Latin America Monocyte Activation Tests Market Attractiveness, by End-user, 2017–2025
Figure 59: Middle East & Africa Monocyte Activation Tests Market Value (US$ Thousand) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 60: Middle East & Africa Monocyte Activation Tests Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 61: Middle East & Africa Monocyte Activation Tests Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 62: Middle East & Africa Monocyte Activation Tests Market Attractiveness, by Product, 2017–2025
Figure 63: Middle East & Africa Monocyte Activation Tests Market Attractiveness, by Source, 2017–2025
Figure 64: Middle East & Africa Monocyte Activation Tests Market Attractiveness, by Application, 2017–2025
Figure 65: Middle East & Africa Monocyte Activation Tests Market Attractiveness, by End-user, 2017–2025
Figure 66: Merck KGaA Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 67: Merck KGaA Research & Development Expenses (US$ Mn), 2014–2016
Figure 68: Merck KGaA Breakdown of Net Sales, by Business Segment, 2016
Figure 69: Merck KGaA Breakdown of Net Sales, by Region, 2016
Figure 70: Thermo Fisher Scientific, Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 71: Thermo Fisher Scientific, Inc. Research & Development Expenses (US$ Mn), 2014–2016
Figure 72: Thermo Fisher Scientific, Inc. Breakdown of Net Sales, by Business Segment, 2016
Figure 73: Thermo Fisher Scientific, Inc. Breakdown of Net Sales, by Region, 2016
Figure 74: Charles River Laboratories International, Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 75: Charles River Laboratories International, Inc. Operating Expenses (US$ Mn), 2014–2016
Figure 76: Charles River Laboratories International, Inc. Breakdown of Net Sales, by Business Segment, 2016
Figure 77: Charles River Laboratories International, Inc. Breakdown of Net Sales, by Geography, 2016
Figure 78: Sanquin Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 79: Sanquin Reagents Segment Revenue (US$ Mn), 2014–2016
Figure 80: Sanquin Breakdown of Net Sales, by Business Segment, 2016
Figure 81: Sanquin Breakdown of Net Sales, by Geography, 2016
Figure 82: Becton, Dickinson and Company Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
Figure 83: Becton, Dickinson and Company Research and Development Expenses (US$ Mn), 2015–2017
Figure 84: Becton, Dickinson and Company Breakdown of Net Sales, by Business Segment, 2017
Figure 85: Becton, Dickinson and Company Breakdown of Net Sales, by Geography, 2017
Figure 86: Solvias AG Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2016
Figure 87: Solvias AG Breakdown of Net Sales, by Geography, 2017
Figure 88: Lonza Group Ltd Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
Figure 89: Lonza Group Ltd Operating Expenses (US$ Mn), 2015–2017
Figure 90: Lonza Group Ltd Breakdown of Net Sales, by Business Segment, 2017
Figure 91: Lonza Group Ltd Breakdown of Net Sales, by Geography, 2015

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

788

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved